{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T07:13:19Z","timestamp":1770016399407,"version":"3.49.0"},"reference-count":7,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2784,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2710.2008.00874.x","type":"journal-article","created":{"date-parts":[[2010,8,20]],"date-time":"2010-08-20T12:09:02Z","timestamp":1282306142000},"page":"75-78","source":"Crossref","is-referenced-by-count":8,"title":["Blood ribavirin concentration in high-dose ribavirin for adenovirus-induced haemorrhagic cystitis - a case report"],"prefix":"10.1155","volume":"33","author":[{"given":"M.","family":"Homma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kohda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2008,1,17]]},"reference":[{"key":"10.1111\/j.1365-2710.2008.00874.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1542\/peds.110.1.e9","article-title":"Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children","volume":"110","author":"Gavin","year":"2002","journal-title":"Pediatrics"},{"key":"10.1111\/j.1365-2710.2008.00874.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/sj.bmt.1704276","article-title":"Oral ribavirin for severe adenovirus infection after allogeneic marrow transplantation","volume":"21","author":"Abe","year":"2003","journal-title":"Bone Marrow Transplantation"},{"key":"10.1111\/j.1365-2710.2008.00874.x-BIB3|cit3","first-page":"363","article-title":"Successful treatment with oral ribavirin of adenovirus-assiciated hemophagocytic syndrome in a stem cell transplantation recipient","volume":"46","author":"Iyama","year":"2005","journal-title":"The Japanese Journal Clinical Hematology"},{"key":"10.1111\/j.1365-2710.2008.00874.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.hepres.2005.10.003","article-title":"Erythrocyte ribavirin concentration for assessing hemoglobin reduction in interferon and ribavirin combination therapy","volume":"34","author":"Inoue","year":"2005","journal-title":"Hepatology Research"},{"key":"10.1111\/j.1365-2710.2008.00874.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1128\/AAC.48.10.3813-3816.2004","article-title":"Liquid chromatography assay for routine monitoring of cellular ribavirin levels in blood","volume":"48","author":"Inoue","year":"2004","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1111\/j.1365-2710.2008.00874.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1128\/AAC.43.11.2716","article-title":"High-performance liquid chromatography determination of ribavirin in whole blood to assess disposition in erythrocytes","volume":"43","author":"Homma","year":"1999","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1111\/j.1365-2710.2008.00874.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1542-3565(04)00064-3","article-title":"Marked elevation of erythrocyte ribavirin levels in interferon and ribavirin-induced anemia","volume":"2","author":"Homma","year":"2004","journal-title":"Clinical Gastroenterology and Hepatology"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2008.00874.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2710.2008.00874.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:02:12Z","timestamp":1671818532000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2710.2008.00874.x"}},"subtitle":["Adenovirus infection and oral ribavirin"],"short-title":[],"issued":{"date-parts":[[2008,1,17]]},"references-count":7,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2710.2008.00874.x","relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1,17]]}}}